胆汁淤积的定义、病因及分类

doi:10.16138/j.1673-6087.2022.01.004

摘要/Abstract

中图分类号:

R575

汪佩文, 董育玮. 胆汁淤积的定义、病因及分类[J]. 内科理论与实践, 2022, 17(01): 15-23.

图/表 1

参考文献 60

[1]	Kuntz K, Kuntz HD. Hepatology: principles and practice[M]. 2nd ed. Heidelberg: Springer Medizin Verlag, 2006:227-242.
[2]	Wu H, Chen C, Ziani S, et al. Fibrotic events in the progression of cholestatic liver disease[J]. Cells, 2021, 10(5): 1107. doi: 10.3390/cells10051107 URL
[3]	中华医学会肝病学分会, 中华医学会消化病学分会, 中华医学会感染病学分会. 胆汁淤积性肝病诊断和治疗共识(2015)[J]. 中华肝脏病杂志, 2015: 23(12): 924-933.
[4]	Sherlock S, Dooley J. Cholestasis//Sherlock S, Dooley J ed. Disease of the liver and biliary system[M]. 11th ed. United Kingdom: Blackwell Publishing, 2002: 219-240.
[5]	王宝恩, 尹姗姗. 胆汁淤积及胆汁淤积性疾病[C]. 全国肝脏疾病学术研讨会, 2003: 6-16.
[6]	胆汁淤积性肝病诊断治疗专家委员会. 胆汁淤积性肝病诊断治疗专家共识[J]. 中华肝脏病杂志, 2009: 1(2): 34-35.
[7]	陈小青, 王迎春. 肝内胆汁淤积性肝病的病因与治疗[J]. 实用肝脏病杂志, 2018, 21(2): 163-165.
[8]	European Association for the Study of the Liver. EASL clinical practice guidelines: management of cholestatic liver diseases[J]. J Hepatol, 2009, 51(2): 237-267. doi: 10.1016/j.jhep.2009.04.009 URL
[9]	Burt A, Portmann B, Ferrell L. MacSween’s pathology of the liver[M]. 6th ed. Elsevier, 2012: 503-562.
[10]	Lefkowitch JH. Scheuer’s liver biopsy interpretation[M]. 9th ed. Elsevier, 2016: 53.
[11]	Hilscher MB, Kamath PS, Eaton JE. Cholestatic liver diseases[J]. Mayo Clin Proc, 2020, 95(10): 2263-2279. doi: 10.1016/j.mayocp.2020.01.015 pmid: 33012354
[12]	中华医学会肝病学分会. 胆汁淤积性肝病管理指南(2021)[J]. 中华内科杂志, 2021, 60(12): 1075-1087.
[13]	Wang K. Molecular mechanisms of liver injury: apoptosis or necrosis[J]. Exp Toxicol Pathol, 2014, 66(8): 351-356. doi: 10.1016/j.etp.2014.04.004 URL
[14]	Jayappa M, Kumar P, Goyal JP. Prolonged cholestasis after acute viral hepatitis: successfully treated with oral steroid[J]. BMJ Case Rep, 2020, 13(5): e234430. doi: 10.1136/bcr-2020-234430 URL
[15]	Shin EC, Jeong SH. Natural history, clinical manifestations, and pathogenesis of hepatitis A[J]. Cold Spring Harb Perspect Med, 2018, 8(9): a031708. doi: 10.1101/cshperspect.a031708 URL
[16]	沈斐斐, 陆伦根. 胆汁淤积性肝病的病因[J]. 实用肝脏病杂志, 2016, 19(6): 644-646.
[17]	Hao H, Cao L, Jiang C, et al. Farnesoid X receptor regulation of the NLRP3 inflammasome underlies cholestasis-associated sepsis[J]. Cell Metab, 2017, 25(4): 856-867. doi: 10.1016/j.cmet.2017.03.007 URL
[18]	Bhogal HK, Sanyal AJ. The molecular pathogenesis of cholestasis in sepsis[J]. Front Biosci(Elite Ed), 2013, E5(1): 87-96.
[19]	Sorrentino P, Tarantino G, Perrella A, et al. A clinical-morphological study on cholestatic presentation of nonalcoholic fatty liver disease[J]. Dig Dis Sci, 2005, 50(6): 1130-1135. doi: 10.1007/s10620-005-2719-1 URL
[20]	Jüngst C, Berg T, Cheng J, et al. Intrahepatic cholestasis in common chronic liver diseases[J]. Eur J Clin Invest, 2013, 43(10): 1069-1083. doi: 10.1111/eci.12128 URL
[21]	中华医学会肝病学分会药物性肝病学组. 药物性肝损伤诊治指南[J]. 中华肝脏病杂志, 2015, 23(11): 810-820.
[22]	Chatterjee S, Annaert P. Drug-induced cholestasis: mechanisms, models, and markers[J]. Curr Drug Metab, 2018, 19(10): 808-818. doi: 10.2174/1389200219666180427165035 pmid: 29708070
[23]	Chalasani NP, Hayashi PH, Bonkovsky HL, et al. ACG clinical guideline: the diagnosis and management of idiosyncratic drug-induced liver injury[J]. Am J Gastroenterol, 2014, 109(7): 950-966. doi: 10.1038/ajg.2014.131 pmid: 24935270
[24]	Chalasani N, Bonkovsky HL, Fontana R, et al. Features and outcomes of 899 patients with drug-induced liver injury[J]. Gastroenterology, 2015, 148(7): 1340-1352. doi: 10.1053/j.gastro.2015.03.006 pmid: 25754159
[25]	Aithal PG, Day CP. The natural history of histologically proved drug induced liver disease[J]. Gut, 1999, 44(5): 731-735. pmid: 10205214
[26]	杨婉娜, 谢雯. 药物性肝损伤的临床表现和分型[J]. 临床肝胆病杂志, 2021, 37(11): 2525-2529.
[27]	Peeraphatdit TB, Wang J, Odenwald MA, et al. Hepatotoxicity from immune checkpoint inhibitors[J]. Hepatology, 2020, 72(1): 315-329. doi: 10.1002/hep.31227 pmid: 32167613
[28]	Schatz SB, Jüngst C, Keitel-Anselmo V, et al. Phenotypic spectrum and diagnostic pitfalls of ABCB4 deficiency depending on age of onset[J]. Hepatol Commun, 2018, 2(5): 504-514. doi: 10.1002/hep4.1149 URL
[29]	Delaunay JL, Durand-Schneider AM, Delautier D, et al. A missense mutation in ABCB4 gene involved in progressive familial intrahepatic cholestasis type 3 leads to a folding defect that can be rescued by low temperature[J]. Hepatology, 2009, 49(4): 1218-1227. doi: 10.1002/hep.22775 URL
[30]	Cabrerizo R, Castaño GO, Burgueño AL, et al. Promoter DNA methylation of farnesoid X receptor and pregnane X receptor modulates the intrahepatic cholestasis of pregnancy phenotype[J]. PLoS One, 2014, 9(1): e87697. doi: 10.1371/journal.pone.0087697 URL
[31]	Massafra V, Pellicciari R, Gioiello A, et al. Progress and challenges of selective Farnesoid X Receptor modulation[J]. Pharmacol Ther, 2018, 191: 162-177. doi: 10.1016/j.pharmthera.2018.06.009 URL
[32]	Song Z, Shi Q. The interaction of PPARα and CYP7B1 with ERα, β impacted the occurrence and development of intrahepatic cholestasis in pregnant rats[J]. Reprod Sci, 2017, 24(4): 627-634. doi: 10.1177/1933719116667223 URL
[33]	Song X, Vasilenko A, Chen Y, et al. Transcriptional dynamics of bile salt export pump during pregnancy: mechanisms and implications in intrahepatic cholestasis of pregnancy[J]. Hepatology, 2014, 60(6): 1993-2007. doi: 10.1002/hep.27171 URL
[34]	Wei W, Hu YY. Expression of hypoxia-regulated genes and glycometabolic genes in placenta from patients with intrahepatic cholestasis of pregnancy[J]. Placenta, 2014, 35(9): 732-736. doi: 10.1016/j.placenta.2014.06.372 pmid: 25063250
[35]	Reyes H, Báez ME, González MC, et al. Selenium, zinc and copper plasma levels in intrahepatic cholestasis of pregnancy, in normal pregnancies and in healthy individuals, in Chile[J]. J Hepatol, 2000, 32(4): 542-549. pmid: 10782901
[36]	Mitra A, Ahn J. Liver disease in patients on total parenteral nutrition[J]. Clin Liver Dis, 2017, 21(4):687-695. doi: 10.1016/j.cld.2017.06.008 URL
[37]	Krebs-Schmitt D, Briem-Richter A, Brinkert F, et al. Alloimmunity and cholestasis after liver transplantation in children with progressive familial intrahepatic cholestasis[J]. J Pediatr Gastroenterol Nutr, 2019, 68(2): 169-174. doi: 10.1097/MPG.0000000000002200 URL
[38]	Amirneni S, Haep N, Gad MA, et al. Molecular overview of progressive familial intrahepatic cholestasis[J]. World J Gastroenterol, 2020, 26(47): 7470-7484. doi: 10.3748/wjg.v26.i47.7470 URL
[39]	董育玮, 李郑红, 汪佩文, 等. 良性复发性肝内胆汁淤积伴先天性黄疸一例报道[J]. 诊断学理论与实践, 2017, 16(4): 434-436.
[40]	唐诚芳, 冯毅, 徐伟, 等. 广州市Citrin缺乏症新生儿筛查及 SLC25A13基因变异分子流行病学特征[J]. 中华实用儿科临床杂志, 2020, 35(11): 838-841.
[41]	宋元宗. Citrin缺陷导致的新生儿肝内胆汁淤积症发病机制和治疗策略:聚焦胆小管膜载体蛋白[J]. 中华实用儿科临床杂志, 2018, 33(19): 1447-1450.
[42]	卢致琨, 刘丽, 李端, 等. Citrin蛋白缺陷所致新生儿肝内胆汁淤积症患儿SLC25A13基因突变分析[J]. 中华实用儿科临床杂志, 2018, 33(8): 615-617.
[43]	Abuduxikuer K, Chen R, Wang ZL, et al. Risk factors associated with mortality in neonatal intrahepatic cholestasis caused by citrin deficiency (NICCD) and clinical implications[J]. BMC Pediatr, 2019, 19(1): 18. doi: 10.1186/s12887-018-1383-5 URL
[44]	Alagille D, Odièvre M, Gautier M, et al. Hepatic ductular hypoplasia associated with characteristic facies, vertebral malformations, retarded physical, mental, and sexual development, and cardiac murmur[J]. J Pediatr, 1975, 86(1): 63-71. doi: 10.1016/S0022-3476(75)80706-2 URL
[45]	Warthen DM, Moore EC, Kamath BM, et al. Jagged1 (JAG1) mutations in Alagille syndrome: increasing the mutation detection rate[J]. Hum Mutat, 2006, 27(5): 436-443. pmid: 16575836
[46]	王建设. Alagille综合征[J]. 中国实用儿科杂志, 2008, 23(1): 3-6.
[47]	郭丽, 宋元宗. Alagille综合征患儿临床治疗管理[J]. 实用肝脏病杂志, 2021, 24(2): 160-163.
[48]	Mutlu M, Aslan Y, Aktürk-Acar F, et al. ARC syndrome[J]. Turk J Pediatr, 2017, 59(4): 487-490.
[49]	Cullinane AR, Straatman-Iwanowska A, Zaucker A, et al. Mutations in VIPAR cause an arthrogryposis, renal dysfunction and cholestasis syndrome phenotype with defects in epithelial polarization[J]. Nat Genet, 2010, 42(4): 303-312. doi: 10.1038/ng.538 pmid: 20190753
[50]	Zhou Y, Zhang J. Arthrogryposis-renal dysfunction-cholestasis(ARC) syndrome: from molecular genetics to clinical features[J]. Ital J Pediatr, 2014, 40: 77. doi: 10.1186/s13052-014-0077-3 URL
[51]	Wang JS, Zhao J, Li LT. ARC syndrome with high GGT cholestasis caused by VPS33B mutations[J]. World J Gastroenterol, 2014, 20(16): 4830-4834. doi: 10.3748/wjg.v20.i16.4830 URL
[52]	Chinnery PF, DiMauro S. Mitochondrial hepatopathies[J]. J Hepatol, 2005, 43(2): 207-209. pmid: 15964657
[53]	张志华, 马雪萍, 郭红梅. TRMU基因突变致线粒体肝病一例[J]. 中华儿科杂志, 2020, 58(7): 602-604.
[54]	中华人民共和国国家卫生健康委员会. 先天性胆汁酸合成障碍诊治指南[J]. 中国实用乡村医生杂志, 2019, 26(9): 12-13.
[55]	代东伶. 先天性胆汁酸合成障碍[J]. 临床儿科杂志, 2015, 33(4): 301-305.
[56]	Tanaka A, Leung PSC, Gershwin ME. Evolution of our understanding of PBC[J]. Best Pract Res Clin Gastroenterol, 2018, 34-35: 3-9. doi: 10.1016/j.bpg.2018.05.008 URL
[57]	Chuang YH, Lian ZX, Cheng CM, et al. Increased levels of chemokine receptor CXCR3 and chemokines IP-10 and MIG in patients with primary biliary cirrhosis and their first degree relatives[J]. J Autoimmun, 2005, 25(2): 126e32.
[58]	Karlsen TH, Folseraas T, Thorburn D, et al. Primary sclerosing cholangitis—a comprehensive review[J]. J Hepatol, 2017, 67(6): 1298-1323. doi: S0168-8278(17)32196-7 pmid: 28802875
[59]	De Boeck K. Cystic fibrosis in the year 2020: A disease with a new face[J]. Acta Paediatr, 2020, 109(5): 893-899. doi: 10.1111/apa.15155 URL
[60]	McDonald GB. Hepatobiliary complications of hemato-poietic cell transplantation, 40 years on[J]. Hepatology, 2010, 51(4): 1450-1460. doi: 10.1002/hep.23533 pmid: 20373370

胆汁淤积的定义、病因及分类

RichHTML

PDF (PC)

可视化

摘要/Abstract

引用本文

使用本文

图/表 1

参考文献 60

相关文章 15

编辑推荐

Metrics

本文评价

[1]	潘琼, 李明巧, 谭雅, 余思睿, 柴进. 胆酸转运蛋白调控胆汁酸代谢的分子机制[J]. 内科理论与实践, 2022, 17(01): 4-10.
[2]	鲁晓岚, 夏巧云. 胆汁淤积性瘙痒发病机制及其治疗研究进展[J]. 内科理论与实践, 2022, 17(01): 43-47.
[3]	宁玲, 刘贞君, 李伟, 刘雯, 李卫, 张振华, 方卫东, 高有方, 郑晓玮, 李磊. 安徽地区胆汁淤积性肝病病理学病因分析[J]. 内科理论与实践, 2022, 17(01): 53-57.
[4]	傅小霜, 李磊. 胆汁淤积性肝病与脂溶性维生素相互作用研究进展[J]. 内科理论与实践, 2022, 17(01): 84-87.
[5]	陆伦根. 重视胆汁淤积性肝病临床管理[J]. 内科理论与实践, 2022, 17(01): 1-3.
[6]	蔡晓波, 王建香, 陆伦根. 胆汁淤积的生物标志物研究进展[J]. 内科理论与实践, 2022, 17(01): 11-14.
[7]	杨玲, 范慧倩, 严胜琦. 胆汁淤积性肝病治疗进展[J]. 内科理论与实践, 2022, 17(01): 29-37.
[8]	曲颖, 陆伦根. 胆汁淤积性疲劳评估和治疗[J]. 内科理论与实践, 2022, 17(01): 38-42.
[9]	王蔚, 王小钦. 缺铁性贫血的病因诊断[J]. 诊断学理论与实践, 2021, 20(06): 529-532.
[10]	高磊, 高艳虹. 肌少症与抑郁症之间关系的研究进展[J]. 内科理论与实践, 2021, 16(06): 442-446.
[11]	刘海燕, 顾蔚蓉. 产后大出血的主要病因变迁和防治策略[J]. 诊断学理论与实践, 2019, 18(06): 619-622.
[12]	陈超波, 蒋兆彦. 胆汁酸代谢与非酒精性脂肪性肝病[J]. 外科理论与实践, 2019, 24(04): 371-374.
[13]	陆伦根, 胡江峰,. 肠道菌群与胆汁酸的研究进展[J]. 内科理论与实践, 2018, 13(06): 329-333.
[14]	李妍, 陆伦根,. 胆汁酸信号通路在慢性肝病中的治疗意义[J]. 内科理论与实践, 2018, 13(06): 394-399.
[15]	李磊, 宁玲,. 胆汁淤积的诊断策略[J]. 内科理论与实践, 2018, 13(06): 339-343.